115 related articles for article (PubMed ID: 9038918)
1. Lysophosphatidylcholine transduces Ca2+ signaling via the platelet-activating factor receptor in macrophages.
Ogita T; Tanaka Y; Nakaoka T; Matsuoka R; Kira Y; Nakamura M; Shimizu T; Fujita T
Am J Physiol; 1997 Jan; 272(1 Pt 2):H17-24. PubMed ID: 9038918
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin transduces Ca2+ signaling via platelet-activating factor receptor.
Nakamura M; Honda Z; Waga I; Matsumoto T; Noma M; Shimizu T
FEBS Lett; 1992 Dec; 314(2):125-9. PubMed ID: 1333988
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi.
Gazos-Lopes F; Oliveira MM; Hoelz LV; Vieira DP; Marques AF; Nakayasu ES; Gomes MT; Salloum NG; Pascutti PG; Souto-Padrón T; Monteiro RQ; Lopes AH; Almeida IC
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3077. PubMed ID: 25101628
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of the intracellular Ca2+ signaling and mRNA expression of platelet-activating factor receptor by estradiol in human uterine endometrial cells.
Sato S; Kume K; Takan T; Mutoh H; Taketani Y; Shimizu T
Adv Exp Med Biol; 1996; 416():95-100. PubMed ID: 9131133
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor induced calcium mobilization and phosphoinositide metabolism in cultured bovine cerebral microvascular endothelial cells.
Lin AY; Rui YC
Biochim Biophys Acta; 1994 Nov; 1224(2):323-8. PubMed ID: 7981248
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a platelet-activating factor receptor on human alveolar macrophages.
Schaberg T; Haller H; Lode H
Biochem Biophys Res Commun; 1991 Jun; 177(2):704-10. PubMed ID: 1646607
[TBL] [Abstract][Full Text] [Related]
7. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4.
Zhu K; Baudhuin LM; Hong G; Williams FS; Cristina KL; Kabarowski JH; Witte ON; Xu Y
J Biol Chem; 2001 Nov; 276(44):41325-35. PubMed ID: 11535583
[TBL] [Abstract][Full Text] [Related]
8. Alteration of platelet-activating factor-induced signal transduction in macrophages by n-3 fatty acids.
Chakrabarti R; Hubbard NE; Lim D; Erickson KL
Cell Immunol; 1997 Jan; 175(1):76-84. PubMed ID: 9015191
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism.
Huang YH; Schäfer-Elinder L; Wu R; Claesson HE; Frostegård J
Clin Exp Immunol; 1999 May; 116(2):326-31. PubMed ID: 10337026
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.
Camussi G; Montrucchio G; Lupia E; Soldi R; Comoglio PM; Bussolino F
J Immunol; 1997 Feb; 158(3):1302-9. PubMed ID: 9013973
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphism of human platelet-activating factor receptor impairs G-protein activation.
Fukunaga K; Ishii S; Asano K; Yokomizo T; Shiomi T; Shimizu T; Yamaguchi K
J Biol Chem; 2001 Nov; 276(46):43025-30. PubMed ID: 11560941
[TBL] [Abstract][Full Text] [Related]
12. Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2+ levels and growth of human prostate cancer cells.
Jan CR; Chao YY
Cell Signal; 2004 Aug; 16(8):959-65. PubMed ID: 15157675
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
15. Receptor-mediated increase in cytosolic calcium in LLC-PK1 cells by platelet activating factor and thromboxane A2.
Ueda N; Mayeux PR; Walker PD; Shah SV
Kidney Int; 1991 Dec; 40(6):1075-81. PubMed ID: 1662319
[TBL] [Abstract][Full Text] [Related]
16. Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins.
Korotaeva AA; Cheglakov IB; Morozkin AD; Suslova IV; Prokazova NV
Membr Cell Biol; 1997; 10(5):521-34. PubMed ID: 9225256
[TBL] [Abstract][Full Text] [Related]
17. Modulatory role of protein kinase C on the signal transduction pathway utilized by platelet-activating factor in eosinophil activation.
Kroegel C; Giembycz MA; Matthys H; Westwick J; Barnes PJ
Am J Respir Cell Mol Biol; 1994 Nov; 11(5):593-9. PubMed ID: 7946388
[TBL] [Abstract][Full Text] [Related]
18. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
Chen J; Giri SN
J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
[TBL] [Abstract][Full Text] [Related]
19. Role of cytoplasmic tail phosphorylation sites of platelet-activating factor receptor in agonist-induced desensitization.
Takano T; Honda Z; Sakanaka C; Izumi T; Kameyama K; Haga K; Haga T; Kurokawa K; Shimizu T
J Biol Chem; 1994 Sep; 269(35):22453-8. PubMed ID: 8071375
[TBL] [Abstract][Full Text] [Related]
20. Platelet-Activating Factor Deteriorates Lysophosphatidylcholine-Induced Demyelination Via Its Receptor-Dependent and -Independent Effects.
Tian Z; Chu T; Shields LBE; Zhu Q; Zhang YP; Kong M; Barnes GN; Wang Y; Shields CB; Cai J
Mol Neurobiol; 2020 Oct; 57(10):4069-4081. PubMed ID: 32661728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
